Genelux Corporation
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
/ 
Frequently asked questions
To buy Genelux Corporation stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Genelux Corporation by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Genelux Corporation is GNLX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Genelux Corporation has its primary listing on NASDAQ (Small cap). You can trade Genelux Corporation with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Genelux Corporation is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Genelux Corporation as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Genelux Corporation.